Related references
Note: Only part of the references are listed.Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK
Merryn Voysey et al.
LANCET (2021)
Interim Results of a Phase 1-2a Trial of Ad26.COV2.S Covid-19 Vaccine
J. Sadoff et al.
NEW ENGLAND JOURNAL OF MEDICINE (2021)
Impaired immunogenicity of BNT162b2 anti-SARS-CoV-2 vaccine in patients treated for solid tumors
J. Barriere et al.
ANNALS OF ONCOLOGY (2021)
COVID-19 vaccine efficacy in patients with chronic lymphocytic leukemia
Lindsey E. Roeker et al.
LEUKEMIA (2021)
Safety and Immunogenicity of a Third Dose of SARS-CoV-2 Vaccine in Solid Organ Transplant Recipients: A Case Series
William A. Werbel et al.
ANNALS OF INTERNAL MEDICINE (2021)
Association of clinical factors and recent anticancer therapy with COVID-19 severity among patients with cancer: a report from the COVID-19 and Cancer Consortium
P. Grivas et al.
ANNALS OF ONCOLOGY (2021)
Reduced SARS-CoV-2 infection and death after two doses of COVID-19 vaccines in a series of 1503 cancer patients
P. Heudel et al.
ANNALS OF ONCOLOGY (2021)
SARS-CoV-2 vaccination in rituximab-treated patients: B cells promote humoral immune responses in the presence of T-cell-mediated immunity
Daniel Mrak et al.
ANNALS OF THE RHEUMATIC DISEASES (2021)
Serological SARS-CoV-2 antibody response, potential predictive markers and safety of BNT162b2 mRNA COVID-19 vaccine in haematological and oncological patients
Magdalena Benda et al.
BRITISH JOURNAL OF HAEMATOLOGY (2021)
Immunogenicity of SARS-CoV-2 messenger RNA vaccines in patients with cancer
Alfredo Addeo et al.
CANCER CELL (2021)
Low rate of seroconversion after mRNA anti-SARS-CoV-2 vaccination in patients with hematological malignancies
Daniel Re et al.
LEUKEMIA & LYMPHOMA (2021)
Immunogenicity of the BNT162b2 COVID-19 mRNA vaccine and early clinical outcomes in patients with haematological malignancies in Lithuania: a national prospective cohort study
Kazimieras Maneikis et al.
LANCET HAEMATOLOGY (2021)
Post-Vaccination Anti-SARS-CoV-2-Antibody Response in Patients with Multiple Myeloma Correlates with Low CD19+B-Lymphocyte Count and Anti-CD38 Treatment
Susanne Ghandili et al.
CANCERS (2021)
Age-dependent Immune Response to the Biontech/Pfizer BNT162b2 Coronavirus Disease 2019 Vaccination
Lisa Mueller et al.
CLINICAL INFECTIOUS DISEASES (2021)
Impact of SARS-CoV-2 variants on the total CD4+ and CD8+ T cell reactivity in infected or vaccinated individuals
Alison Tarke et al.
CELL REPORTS MEDICINE (2021)
Clinical impact of COVID-19 on patients with cancer (CCC19): a cohort study
Nicole M. Kuderer et al.
LANCET (2020)
Remdesivir for the Treatment of Covid-19-Final Report
John H. Beigel et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Validation of a commercially available SARS-CoV-2 serological immunoassay
B. Meyer et al.
CLINICAL MICROBIOLOGY AND INFECTION (2020)
High mortality rate in cancer patients with symptoms of COVID-19 with or without detectable SARS-COV-2 on RT-PCR
Souad Assaad et al.
EUROPEAN JOURNAL OF CANCER (2020)
COVID-19 and Cancer: Current Challenges and Perspectives
Ziad Bakouny et al.
CANCER CELL (2020)
Aging and the immune system: An overview
Amir A. Sadighi Akha
JOURNAL OF IMMUNOLOGICAL METHODS (2018)